Institute Diabetes and Metabolic Disease — Newark, Delaware

Institute Diabetes and Metabolic Disease is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Institute Diabetes and Metabolic Disease has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Ono Pharma USA Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute Diabetes and Metabolic Disease?

Institute Diabetes and Metabolic Disease has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute Diabetes and Metabolic Disease conducted?

Institute Diabetes and Metabolic Disease has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Institute Diabetes and Metabolic Disease accredited by Crixeo Health?

Institute Diabetes and Metabolic Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute Diabetes and Metabolic Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.